CohBar, Inc. announced that it has appointed Steven B. Engle as its Chief Executive Officer, effective May 15, 2019. The company's interim Chief Executive Officer Dr. Philippe Calais will continue to serve on the company's Board, a position he has held since June 2018. Steven Engle has over 20 years of executive leadership experience with public biotech companies developing breakthrough products in metabolic, autoimmune, oncologic and infectious disease areas. Before joining CohBar, Mr. Engle served for seven years as CEO of Averigon Consulting, an advisory firm to the life science industry, supporting companies through product partnering, regulatory planning, investor relations and executive management. Previously, he served for four years as Chairman and CEO of XOMA Corporation. Prior to XOMA, Mr. Engle served for fourteen years as Chairman and CEO of La Jolla Pharmaceutical Company.